Correlation Between Biomerica and Neuropace

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biomerica and Neuropace at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biomerica and Neuropace into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biomerica and Neuropace, you can compare the effects of market volatilities on Biomerica and Neuropace and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biomerica with a short position of Neuropace. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biomerica and Neuropace.

Diversification Opportunities for Biomerica and Neuropace

-0.11
  Correlation Coefficient

Good diversification

The 3 months correlation between Biomerica and Neuropace is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Biomerica and Neuropace in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neuropace and Biomerica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biomerica are associated (or correlated) with Neuropace. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neuropace has no effect on the direction of Biomerica i.e., Biomerica and Neuropace go up and down completely randomly.

Pair Corralation between Biomerica and Neuropace

Given the investment horizon of 90 days Biomerica is expected to under-perform the Neuropace. In addition to that, Biomerica is 1.08 times more volatile than Neuropace. It trades about -0.05 of its total potential returns per unit of risk. Neuropace is currently generating about 0.1 per unit of volatility. If you would invest  144.00  in Neuropace on September 22, 2024 and sell it today you would earn a total of  1,009  from holding Neuropace or generate 700.69% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Biomerica  vs.  Neuropace

 Performance 
       Timeline  
Biomerica 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Biomerica are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Biomerica is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Neuropace 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent fundamental indicators, Neuropace exhibited solid returns over the last few months and may actually be approaching a breakup point.

Biomerica and Neuropace Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biomerica and Neuropace

The main advantage of trading using opposite Biomerica and Neuropace positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biomerica position performs unexpectedly, Neuropace can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neuropace will offset losses from the drop in Neuropace's long position.
The idea behind Biomerica and Neuropace pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk